Low Price Shares locked in Upper Circuit on September 27,2022

low price stocks

Stock Recommendations
by 5paisa Research Team Last Updated: 2022-09-27T12:24:47+05:30

On Tuesday, the benchmark indices opened higher but slipped into red towards the afternoon session. 

At 11 am, Sensex was down 28.29 points or 0.05% at 57,116.93. Nifty is down 25.00 points or 0.15% at 16,991.30. About 1476 shares have advanced, 1528 shares declined, and 118 shares are unchanged on the BSE. Powergrid Corporation, HUL, ITC, IndusInd Bank and HCL Technologies were the top gainers whereas Tata Steel, Titan, Kotak Mahindra, Axis Bank and Maruti Suzuki were the top losers.

List of Low Price Shares Today: September 27

Following is the list of low price stocks locked in the upper circuit on September 27. Keep a close eye on these counters for the upcoming sessions.

Sr No.  

Security Name  

LTP (Rs)  

% change in price  

1  

Captain Technocast  

72.6  

10  

2  

Mid India Industries  

14.28  

5  

3  

Indo Euro Indchem  

23.52  

5  

4  

Welterman International  

10.92  

5  

5  

KJMC Financial Services  

34.65  

5  

6  

Jayatma Industries  

11.13  

5  

7  

Step Two Corporation  

22.05  

5  

8  

Monind  

15.34  

5  

9  

Fruition Venture  

14.29  

5  

10  

Aananda Lakshmi Spinning Mills  

12.6  

On the sectoral front, all the sectors traded marginally lower with BSE Metal Index being hit the most, contracting more than 1%. The top three stocks dragging the BSE Metal Index were Tata Steel, Jindal Steel and JSW Steel which declined up to 2.5%.

The broader markets were showing a mixed performance as compared to the benchmark indices with BSE MidCap Index losing 0.41% and the BSE SmallCap trading marginally higher at 0.31%. The top three midcap stocks were Indraprastha Gas, Gujarat Gas and Muthoot Finance whereas the top three small-cap stocks were Hindustan Construction, State Trading Corporation and Jtekt India.

Among individual stocks, shares of Metro Brands jumped 6% to hit a new high of Rs 948.85 per share, on a strong business outlook. On the other hand, shares of Aurobindo Pharma dipped 6% in a week after the company’s arm Aurolife received EIR for its US plant from the USFDA.

Start Investing in 5 mins*

Get Benefits worth 2100* | Rs. 20 Flat Per Order | 0% Brokerage

About the Author

Our research team is composed of some highly qualified research professionals, their expertise range across sectors.

Disclaimer

Investment/Trading in securities Market is subject to market risk, past performance is not a guarantee of future performance. The risk of loss in trading and investment in Securities markets including Equites and Derivatives can be substantial. Also, The

Open Free Demat Account

& get benefits worth 2100*

Resend OTP
Please Enter OTP
  • Have Promo code?
  • Use code ACT2100
Enter Promo code
Account belongs to

By proceeding, you agree to the T&C.

Start Investing Now!

Open Free Demat Account in 5 mins

Enter Valid Mobile Number